AUG 2014 ARTICLE LIST >>
PharmaTutor (August- 2014)
ISSN: 2347 - 7881
(Volume 2, Issue 8)
Received On: 13/06/2014; Accepted On: 19/06/2014; Published On: 01/08/2014
AUTHORS: Shambhavi Singh
Department of Pharmacology, Singhania University,
Jhunjhunu, Rajasthan
shambhavisingh6777@gmail.com
ABSTRACT:
Atherosclerosis a disease of the larger arteries is the major cause of heart disease and stroke. Nowadays, serve as leading reason of death not only in senility peoples but in youth also worldwide. Researches in the atherosclerosis disease have led to many persuasive hypotheses about the pathophysiology of atherosclerotic lesion development and of tricky situation such as myocardial infarction and stroke. It is now unambiguous that atherosclerosis is not simply an unavoidable degenerative consequence of ageing, but somewhat a chronic inflammatory situation that can be transformed into an acute clinical occasion by plaque rupture and thrombosis. Evidently, crystallization of information concerning atherosclerosis will approach only by the appropriate free interplay and satisfactory fusion of the three foremost looms to the trouble, epidemiologic, clinical and investigational.
How to cite this article: S Singh; Atherosclerosis: Research review; PharmaTutor; 2014; 2(8); 162-169
[ABSTRACT WITH CITATION] [VIEW AS HTML]
REFERENCES:
1. Humphrey LL, FuR, Rogers K, Freeman M, Helfand M. “Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.” Available at: Mayo ClinProc 2008;83(11):1203–12.
2. Fowkes FG, Murray GD, Butcher I, et al. “Ankle brachial index combined with Framingham risks core to predict cardio vascular events and mortality: a meta-analysis.” Available at: JAMA 2008;300(2):197–208.
3. Fleming C, Whitlock E P, Beil T L, Lederle F A. “Screening for abdominal aorticaneurysm:abest-evidence system atic review for the U.S. Preventive Services Task Force.” Available at: Ann Intern Med 2005;142(3):203–11.
4. Lederle F A. “Management of small abdominal aortic aneurysms.” Available at: Ann Intern Med 1990;113(10):731–2.
5. Kent KC, Jaff MR, Zwolak RM, et al. “Screening for abdominal aortic aneurysm: a consensus statement.” Available at: J VascSurg 2004;39(1):267–9.
6. Mayfield JA, Reiber GE, Pogach LM, Janisse D, Sanders LJ. “Preventive foot care in diabetes.” Available at: Diabetes Care 2004;27(1S):S63–4.
7. Hardman, Gilman, Limbard: Goodman & Gilman’s pharmacological basis of therapeutics. Available at: McGraw Hill medical publishers, 10th edition, 977-986.
8. Rang, Dale, Ritter, Henderson, and Flower: A Text Book of Rang & Dale’s Pharmacology. Available at: Elsevier churchillivingstone publishers, 7th edition, 285-293, 604.
9. Alexandra Lucasa, Erbin Daia, Li-Ying Liua, Patric N Nationb et al “Atherosclerosis in Marek's disease virus infected hypercholesterolemic roosters is reduced by HMGCoA reductase and ACE inhibitor therapy” available at oxford journal, cardiovascular research Volume 38, Issue 1, 237-246.
10. Cho H-J, Cho H-J, Lee H-J, Song M-K, Seo J-Y, et al. "Vascular Calcifying Progenitor Cells Possess Bidirectional Differentiation Potentials" PLoS Biol , April,2013,doi:10.1371/journal.pbio.1001534
11. Ortega RN MSN, CNS “ATHEROSCLEROSIS PATHOLOGY” Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
12. Diagnosing Atherosclerosis, Available at: news-medical cited on. 16 January 2014
13. "Linus Pauling Institute at Oregon State University". lpi.oregonstate.edu. Archived from the original on 7 April 2010. Retrieved 2010-03-25.
14. Barter PJ, Caulfield M, Eriksson M, et al. "Effects of torcetrapib in patients at high risk for coronary events". N Engl J Med. November 2007, 357 (21): 2109-22.doi:10.1056/NEJMoa0706628. PMID 17984165.
15. Sue Hughes (March 26, 2007). "ERASE: New HDL mimetic shows promise". HeartWire. Hewing B, Parathath S, Mai CK, et al."Rapid regression of atherosclerosis with MTP inhibitor tre". J. Atherosclerosis March 2013, 227 (1): 125–9.
16. Jan Nilsson; Göran K. Hansson; Prediman K. Shah. "Immunomodulation of Atherosclerosis – Implications for Vaccine Development—ATVB In Focus".Arteriosclerosis, Thrombosis, and Vascular Biology 2005, 5 (1): 18–28.
17. Hermansson A, Johansson DK, Ketelhuth DF. "Immunotherapy with Tolerogenic Apolipoprotein B-100–Loaded Dendritic Cells Attenuates Atherosclerosis in Hypercholesterolemic Mice". J Circ.et al. March 2011, 123 (10): 91.
.png)
